Kizzmekia S Corbett-Helaire, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antibodies, Neutralizing | 31 | 2024 | 1931 | 2.710 |
Why?
|
Antibodies, Viral | 34 | 2024 | 3142 | 2.540 |
Why?
|
Viral Vaccines | 7 | 2023 | 596 | 1.320 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 3 | 2022 | 158 | 0.800 |
Why?
|
Laboratory Personnel | 1 | 2020 | 19 | 0.740 |
Why?
|
Primates | 3 | 2024 | 523 | 0.720 |
Why?
|
Moral Obligations | 1 | 2020 | 93 | 0.690 |
Why?
|
Ebolavirus | 1 | 2022 | 251 | 0.690 |
Why?
|
Coronavirus Infections | 11 | 2021 | 3076 | 0.680 |
Why?
|
Vaccines, Virus-Like Particle | 2 | 2019 | 45 | 0.670 |
Why?
|
Pandemics | 9 | 2022 | 8611 | 0.660 |
Why?
|
Dengue Virus | 3 | 2018 | 200 | 0.650 |
Why?
|
Health Planning | 1 | 2020 | 231 | 0.640 |
Why?
|
Image Cytometry | 1 | 2018 | 53 | 0.630 |
Why?
|
Influenza Vaccines | 3 | 2022 | 759 | 0.610 |
Why?
|
Dengue | 3 | 2018 | 254 | 0.600 |
Why?
|
Macaca mulatta | 8 | 2023 | 2316 | 0.600 |
Why?
|
Vaccines | 2 | 2023 | 832 | 0.590 |
Why?
|
Pneumonia, Viral | 7 | 2020 | 3196 | 0.590 |
Why?
|
Antigens, Viral | 2 | 2019 | 980 | 0.570 |
Why?
|
Resilience, Psychological | 1 | 2024 | 772 | 0.530 |
Why?
|
Career Choice | 1 | 2021 | 752 | 0.500 |
Why?
|
Mentors | 1 | 2020 | 660 | 0.490 |
Why?
|
Research | 1 | 2021 | 1976 | 0.430 |
Why?
|
High-Throughput Screening Assays | 1 | 2018 | 933 | 0.420 |
Why?
|
Cross Reactions | 8 | 2021 | 818 | 0.410 |
Why?
|
Immunization, Secondary | 4 | 2021 | 368 | 0.400 |
Why?
|
Mesocricetus | 2 | 2021 | 252 | 0.380 |
Why?
|
Immunization, Passive | 3 | 2021 | 616 | 0.350 |
Why?
|
Virus Replication | 4 | 2021 | 2430 | 0.350 |
Why?
|
Bottle Feeding | 2 | 2000 | 67 | 0.330 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2021 | 748 | 0.330 |
Why?
|
RNA, Viral | 3 | 2021 | 2836 | 0.310 |
Why?
|
Vaccination | 8 | 2024 | 3356 | 0.310 |
Why?
|
Epitopes | 4 | 2023 | 2502 | 0.310 |
Why?
|
Neutralization Tests | 4 | 2021 | 728 | 0.290 |
Why?
|
Nose | 2 | 2021 | 519 | 0.280 |
Why?
|
Receptors, Virus | 6 | 2020 | 639 | 0.280 |
Why?
|
Coronavirus | 2 | 2020 | 149 | 0.260 |
Why?
|
Th1 Cells | 2 | 2021 | 1031 | 0.260 |
Why?
|
Animals | 28 | 2024 | 167777 | 0.250 |
Why?
|
B-Lymphocytes | 1 | 2019 | 4738 | 0.250 |
Why?
|
Vaccines, Synthetic | 3 | 2021 | 617 | 0.230 |
Why?
|
Antibody Affinity | 2 | 2021 | 245 | 0.230 |
Why?
|
Vero Cells | 2 | 2021 | 482 | 0.220 |
Why?
|
Orthomyxoviridae Infections | 2 | 2022 | 250 | 0.210 |
Why?
|
Coronavirus OC43, Human | 1 | 2021 | 18 | 0.200 |
Why?
|
Protein Multimerization | 4 | 2020 | 979 | 0.200 |
Why?
|
Respiratory Syncytial Viruses | 3 | 2015 | 167 | 0.200 |
Why?
|
Influenza A Virus, H5N1 Subtype | 1 | 2022 | 113 | 0.190 |
Why?
|
Viral Load | 2 | 2021 | 3321 | 0.190 |
Why?
|
Antibody Formation | 2 | 2023 | 1400 | 0.190 |
Why?
|
Science | 1 | 2024 | 239 | 0.190 |
Why?
|
Sri Lanka | 3 | 2018 | 92 | 0.190 |
Why?
|
Breast Feeding | 2 | 2000 | 1355 | 0.190 |
Why?
|
National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2020 | 62 | 0.180 |
Why?
|
Maternal-Child Nursing | 1 | 2000 | 3 | 0.180 |
Why?
|
Cell Line | 5 | 2021 | 15594 | 0.180 |
Why?
|
Immunization Schedule | 1 | 2021 | 223 | 0.180 |
Why?
|
RNA, Messenger | 5 | 2022 | 12760 | 0.180 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2020 | 365 | 0.170 |
Why?
|
Seroepidemiologic Studies | 3 | 2020 | 394 | 0.170 |
Why?
|
North Carolina | 1 | 2020 | 323 | 0.170 |
Why?
|
Immunity, Mucosal | 2 | 2021 | 481 | 0.170 |
Why?
|
Ferritins | 2 | 2020 | 597 | 0.170 |
Why?
|
Lung | 4 | 2021 | 9985 | 0.160 |
Why?
|
Biotechnology | 1 | 2021 | 281 | 0.160 |
Why?
|
Molecular Probes | 1 | 2020 | 310 | 0.160 |
Why?
|
Immunoglobulin G | 5 | 2021 | 4540 | 0.160 |
Why?
|
Fathers | 1 | 2021 | 377 | 0.160 |
Why?
|
Nanoparticles | 2 | 2020 | 1940 | 0.160 |
Why?
|
Infant Food | 1 | 1999 | 140 | 0.150 |
Why?
|
Nasal Mucosa | 1 | 2021 | 412 | 0.150 |
Why?
|
Quarantine | 1 | 2020 | 176 | 0.150 |
Why?
|
History, 21st Century | 2 | 2021 | 1573 | 0.150 |
Why?
|
Awards and Prizes | 1 | 2021 | 359 | 0.140 |
Why?
|
Mice | 12 | 2023 | 81107 | 0.140 |
Why?
|
Toll-Like Receptor 4 | 1 | 2020 | 577 | 0.140 |
Why?
|
Protein Stability | 1 | 2018 | 567 | 0.140 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2020 | 851 | 0.130 |
Why?
|
Research Personnel | 1 | 2021 | 582 | 0.130 |
Why?
|
Respiratory Syncytial Virus Infections | 2 | 2011 | 364 | 0.130 |
Why?
|
Protein Structure, Secondary | 1 | 2018 | 1229 | 0.130 |
Why?
|
Humans | 38 | 2024 | 758381 | 0.130 |
Why?
|
Biomedical Research | 2 | 2021 | 3417 | 0.120 |
Why?
|
Vulnerable Populations | 1 | 2020 | 699 | 0.120 |
Why?
|
Antigens | 1 | 2020 | 1445 | 0.120 |
Why?
|
Cryoelectron Microscopy | 4 | 2020 | 642 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 748 | 0.120 |
Why?
|
Immunologic Memory | 1 | 2021 | 1353 | 0.120 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2000 | 3990 | 0.120 |
Why?
|
Virus Diseases | 1 | 2020 | 719 | 0.120 |
Why?
|
Drug Carriers | 1 | 2019 | 705 | 0.120 |
Why?
|
Minority Groups | 1 | 2021 | 1206 | 0.120 |
Why?
|
Protein Binding | 4 | 2020 | 9312 | 0.110 |
Why?
|
Peptidyl-Dipeptidase A | 3 | 2020 | 361 | 0.110 |
Why?
|
Female | 17 | 2023 | 390316 | 0.110 |
Why?
|
Polysaccharides | 1 | 2020 | 1007 | 0.110 |
Why?
|
Disease Outbreaks | 1 | 2022 | 1755 | 0.110 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1444 | 0.100 |
Why?
|
Antibodies, Monoclonal | 4 | 2022 | 9160 | 0.100 |
Why?
|
Influenza, Human | 1 | 2022 | 1516 | 0.090 |
Why?
|
Respiratory Syncytial Virus Vaccines | 1 | 2010 | 35 | 0.090 |
Why?
|
Plasmids | 1 | 2015 | 2275 | 0.080 |
Why?
|
Male | 10 | 2023 | 358742 | 0.080 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 4353 | 0.080 |
Why?
|
Antiviral Agents | 1 | 2021 | 3056 | 0.080 |
Why?
|
Papillomavirus Vaccines | 1 | 2015 | 497 | 0.080 |
Why?
|
T-Lymphocytes | 3 | 2020 | 10171 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2020 | 4549 | 0.080 |
Why?
|
Antibody Specificity | 2 | 2020 | 1060 | 0.080 |
Why?
|
Virion | 1 | 2010 | 421 | 0.080 |
Why?
|
Poverty | 1 | 2000 | 2692 | 0.080 |
Why?
|
Mothers | 1 | 1999 | 2189 | 0.080 |
Why?
|
Immune Evasion | 2 | 2021 | 362 | 0.070 |
Why?
|
Parents | 1 | 2021 | 3548 | 0.070 |
Why?
|
Peptide Hydrolases | 2 | 2021 | 622 | 0.070 |
Why?
|
Mucous Membrane | 1 | 2010 | 656 | 0.070 |
Why?
|
Mice, Inbred BALB C | 3 | 2021 | 6209 | 0.070 |
Why?
|
Feeding Behavior | 1 | 1999 | 3183 | 0.070 |
Why?
|
Glycosylation | 2 | 2020 | 1095 | 0.070 |
Why?
|
Infant | 5 | 2023 | 36054 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2021 | 18125 | 0.060 |
Why?
|
Models, Molecular | 3 | 2020 | 5410 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 3801 | 0.060 |
Why?
|
Mutation | 4 | 2021 | 29915 | 0.060 |
Why?
|
Virus Internalization | 2 | 2018 | 494 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14641 | 0.050 |
Why?
|
Papillomavirus Infections | 1 | 2015 | 1612 | 0.050 |
Why?
|
Crystallography, X-Ray | 2 | 2018 | 1974 | 0.050 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2015 | 2016 | 0.050 |
Why?
|
Hemagglutinins | 1 | 2022 | 113 | 0.050 |
Why?
|
Recurrence | 1 | 2014 | 8426 | 0.050 |
Why?
|
Ferrets | 1 | 2022 | 177 | 0.050 |
Why?
|
Viral Matrix Proteins | 2 | 2015 | 196 | 0.050 |
Why?
|
Common Cold | 1 | 2021 | 63 | 0.050 |
Why?
|
Antigen-Antibody Reactions | 1 | 2021 | 346 | 0.050 |
Why?
|
Skin | 1 | 2015 | 4464 | 0.050 |
Why?
|
Protein Conformation | 2 | 2020 | 3966 | 0.050 |
Why?
|
Macaca | 1 | 2022 | 409 | 0.050 |
Why?
|
Epitope Mapping | 1 | 2021 | 297 | 0.050 |
Why?
|
Camelids, New World | 1 | 2020 | 20 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20052 | 0.040 |
Why?
|
Binding Sites, Antibody | 1 | 2020 | 337 | 0.040 |
Why?
|
Biotinylation | 1 | 2020 | 184 | 0.040 |
Why?
|
Plasma Cells | 1 | 2024 | 591 | 0.040 |
Why?
|
South Carolina | 1 | 2000 | 100 | 0.040 |
Why?
|
Asparagine | 1 | 2020 | 119 | 0.040 |
Why?
|
Dendritic Cells | 1 | 2011 | 2723 | 0.040 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2021 | 444 | 0.040 |
Why?
|
Nursing Methodology Research | 1 | 1999 | 64 | 0.040 |
Why?
|
Adult | 7 | 2021 | 219916 | 0.040 |
Why?
|
Child, Preschool | 3 | 2020 | 42058 | 0.040 |
Why?
|
Anthropology, Cultural | 1 | 1999 | 102 | 0.040 |
Why?
|
United States | 3 | 2021 | 72140 | 0.040 |
Why?
|
Immunization | 1 | 2022 | 1227 | 0.040 |
Why?
|
Adjuvants, Immunologic | 1 | 2024 | 1038 | 0.040 |
Why?
|
Viral Tropism | 1 | 2018 | 102 | 0.040 |
Why?
|
Coronaviridae | 1 | 2017 | 13 | 0.040 |
Why?
|
Trypsin | 1 | 2018 | 496 | 0.040 |
Why?
|
Cricetinae | 1 | 2021 | 2426 | 0.040 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2021 | 791 | 0.040 |
Why?
|
Protease Inhibitors | 1 | 2021 | 754 | 0.040 |
Why?
|
Surface Properties | 1 | 2020 | 1159 | 0.040 |
Why?
|
Helicobacter pylori | 1 | 2020 | 376 | 0.040 |
Why?
|
Multienzyme Complexes | 1 | 2020 | 665 | 0.040 |
Why?
|
Proline | 1 | 2018 | 456 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2021 | 2753 | 0.030 |
Why?
|
Immunoglobulins | 1 | 2020 | 859 | 0.030 |
Why?
|
Drug Design | 1 | 2021 | 1049 | 0.030 |
Why?
|
Mother-Child Relations | 1 | 2000 | 494 | 0.030 |
Why?
|
Animals, Newborn | 1 | 2021 | 2673 | 0.030 |
Why?
|
World Health Organization | 1 | 2021 | 1312 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2021 | 2850 | 0.030 |
Why?
|
Genome, Viral | 1 | 2018 | 658 | 0.030 |
Why?
|
Viral Fusion Proteins | 1 | 2015 | 99 | 0.030 |
Why?
|
Protein Structure, Quaternary | 1 | 2016 | 428 | 0.030 |
Why?
|
Models, Psychological | 1 | 1999 | 830 | 0.030 |
Why?
|
Membrane Fusion | 1 | 2016 | 266 | 0.030 |
Why?
|
Travel | 1 | 2020 | 785 | 0.030 |
Why?
|
Microinjections | 1 | 2015 | 321 | 0.030 |
Why?
|
Young Adult | 4 | 2021 | 58808 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2018 | 18942 | 0.030 |
Why?
|
Molecular Typing | 1 | 2014 | 116 | 0.030 |
Why?
|
Luciferases | 1 | 2015 | 714 | 0.030 |
Why?
|
Child | 3 | 2020 | 79813 | 0.030 |
Why?
|
Prospective Studies | 2 | 2014 | 54136 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2021 | 1807 | 0.030 |
Why?
|
Human papillomavirus 16 | 1 | 2015 | 266 | 0.030 |
Why?
|
Immunity, Humoral | 1 | 2017 | 604 | 0.030 |
Why?
|
Administration, Cutaneous | 1 | 2015 | 712 | 0.030 |
Why?
|
Protein Subunits | 1 | 2016 | 942 | 0.030 |
Why?
|
Needles | 1 | 2015 | 451 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2017 | 3069 | 0.020 |
Why?
|
Transgenes | 1 | 2015 | 1007 | 0.020 |
Why?
|
Immune System Phenomena | 1 | 2011 | 17 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2015 | 1527 | 0.020 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2011 | 72 | 0.020 |
Why?
|
Administration, Mucosal | 1 | 2010 | 6 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2020 | 6520 | 0.020 |
Why?
|
Administration, Intravaginal | 1 | 2010 | 151 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2020 | 26182 | 0.020 |
Why?
|
Binding Sites | 1 | 2018 | 6036 | 0.020 |
Why?
|
Bacteria | 1 | 2020 | 2199 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6768 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2018 | 6068 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2018 | 4258 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2016 | 3796 | 0.020 |
Why?
|
Vaccines, DNA | 1 | 2010 | 286 | 0.020 |
Why?
|
Adolescent | 3 | 2021 | 87888 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10747 | 0.020 |
Why?
|
DNA, Viral | 1 | 2015 | 2194 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2010 | 1759 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2021 | 11070 | 0.020 |
Why?
|
Bacterial Proteins | 1 | 2020 | 3824 | 0.020 |
Why?
|
Immunoglobulin A | 1 | 2010 | 979 | 0.020 |
Why?
|
Middle Aged | 4 | 2021 | 219560 | 0.020 |
Why?
|
Urban Population | 1 | 2014 | 2023 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2011 | 1871 | 0.020 |
Why?
|
Epithelium | 1 | 2010 | 1605 | 0.020 |
Why?
|
Vagina | 1 | 2010 | 838 | 0.010 |
Why?
|
Aged | 3 | 2021 | 168217 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15646 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2020 | 8946 | 0.010 |
Why?
|
Viral Proteins | 1 | 2010 | 1803 | 0.010 |
Why?
|
Gene Expression | 1 | 2015 | 7583 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 39873 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2010 | 5490 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 25953 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15785 | 0.010 |
Why?
|
Cytokines | 1 | 2011 | 7338 | 0.010 |
Why?
|
Incidence | 1 | 2014 | 21273 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2011 | 11471 | 0.010 |
Why?
|